π-Bridge Substitution in DASAs: The Subtle Equilibrium between Photochemical Improvements and Thermal Control**

Donor–acceptor Stenhouse adducts (DASAs) are playing an outstanding role as innovative and versatile photoswitches. Until now, all the efforts have been spent on modifying the donor and acceptor moieties to modulate the absorption energy and improve the cyclization and reversion kinetics. However, there is a strong dependence on specific structural modifications and a lack of predictive behavior, mostly owing to the complex photoswitching mechanism. Here, by means of a combined experimental and theoretical study, the effect of chemical modification of the π-bridge linking the donor and acceptor moieties is systematically explored, revealing the significant impact on the absorption, photocyclization, and relative stability of the open form. In particular, a position along the π-bridge is found to be the most suited to redshift the absorption while preserving the cyclization. However, thermal back-reaction to the initial isomer is blocked. These effects are explained in terms of an increased acceptor capability offered by the π-bridge substituent that can be modulated. This strategy opens the path toward derivatives with infra-red absorption and a potential anchoring point for further functionalization.     

Analytical performance of glucometers in a tertiary care hospital

Point-of-care (POC) testing of glucose (glucometers) represents a convenient alternative to monitor glycemia since the measurement procedure is performed without delay after sampling of the capillary blood, thereby avoiding the metabolism by the blood cells of glucose present in plasma. Likely because of sample instability, there is no proficiency test provider in Brazil for this type of POC sample. In this context, this study aimed to evaluate the analytical performance of glucometers used in a tertiary care hospital. The glucometers used were the Accu-Chek Performa^® model from Roche Diagnostics, which use the principle of amperometry. The reference method was the reaction with modified hexokinase/glucose-6-phosphate in a Dimension^® device. The stability evaluation of the control samples showed that it can be performed up to 90 min after the collection of whole blood samples. In the two rounds performed, only one result of the 17 glucometers evaluated was out of the threshold of two standard deviation. Thus, this method for control of glucometers met the expectations and enabled comparing the glucometers in a hospital. Given the current quality guidelines, daily internal quality control of glucometers is recommended, besides at least two annual comparisons between the results of the glucometers and the reference method and one EQA every 3 months.     

Capping [H<Subscript>8−n</Subscript>Ni<Subscript>42</Subscript>C<Subscript>8</Subscript>(CO)<Subscript>44</Subscript>]<Superscript>n−</Superscript> (n = 6, 7, 8) Octa-carbide Carbonyl Nanoclusters with [Ni(CO)] and [CuCl] Fragments

The reactions of [Ni₁₆(C₂)₂(CO)₂₃]^4? and [Ni₃₈C₆(CO)₄₂]^6? with CuCl afforded mixtures of the previously reported [HNi₄₂C₈(CO)₄₄(CuCl)]^7? bimetallic octa-carbide cluster and the new [HNi₄₃C₈(CO)₄₅]^7? and [HNi₄₄C₈(CO)₄₆]^7? homo-metallic octa-carbides. The three species have very similar properties resulting always in co-crystals such as [NMe₄]₇[HNi_42+2xC₈(CO)_44+2x(CuCl)_1?x]·6.5MeCN (x = 0.14) (86% [HNi₄₂C₈(CO)₄₄(CuCl)]^7?, 14%[HNi₄₃C₈(CO)₄₅]^7?/[HNi₄₄C₈(CO)₄₆]^7?) and [NMe₄]₇[HNi_42+2xC₈(CO)_44+2x(CuCl)_1?x]·5.5MeCN (x = 0.30) (70% [HNi₄₂C₈(CO)₄₄(CuCl)]^7?, 30% [HNi₄₃C₈(CO)₄₅]^7?/[HNi₄₄C₈(CO)₄₆]^7?). The new homo-metallic octa-carbides can be obtained free from the Ni–Cu octa-carbido cluster by reacting [Ni₁₀(C₂)(CO)₁₆]^2? in thf with a stoichiometric amount of CuCl, and crystals of [NMe₄]₆[H₂Ni_43+xC₈(CO)_45+x]·6MeCN (x = 0.72), which contain [H₂Ni₄₄C₈(CO)₄₆]^6? (72%) and [H₂Ni₄₃C₈(CO)₄₅]^6? (28%), have been obtained. Despite the different charges and compositions, these anions display almost identical structures, which are also closely related to those previously reported for the bimetallic Ni–Cd octa-carbido clusters [Ni_42+xC₈(CO)_44+x(CdCl)]^7? and [HNi_42+xC₈(CO)_44+x(CdBr)]^6?. Indeed, all these clusters are based on the same Ni₄₂C₈ cage decorated by miscellaneous [CdX]⁺ (X = Cl, Br), [CuCl] and [Ni(CO)] fragments.     

Malva sylvestris L. extract suppresses desferrioxamine‐induced PGE2 and PGD2 release in differentiated U937 cells: the development and validation of an LC‐MS/MS method for prostaglandin quantification

Malva sylvestris is a species used worldwide as an alternative to anti‐inflammatory therapies; however, its mechanism of action remains unknown. In this paper, the anti‐inflammatory effects of M. sylvestris alcoholic extracts were evaluated by measuring the pro‐inflammatory mediators PGE₂ and PGD₂ in desferrioxamine‐stimulated phorbol 12‐myristate 13‐acetate‐differentiated U937 cells. An HPLC‐DAD fingerprint of the M. sylvestris extract was performed and caffeic acid, ferulic acid and scopoletin were identified and quantified. An HPLC‐MS/MS method was developed and validated to separate and measure the prostaglandins. The lower limits of detection (~0.5 ng/mL for PGE₂ and PGD₂) and quantification (1.0 ng/mL for PGE₂ and PGD₂) indicated that the method is highly sensitive. The calibration curves showed excellent coefficients of correlation (r > 0.99) over the range of 1.0–500.0 ng/mL, and at different levels, the accuracy ranged from 96.4 to 106.4% with an RSD < 10.0% for the precision study. This method was successfully applied using U937‐d cells. A significant dose‐dependent reduction of PGE₂ and PGD₂ levels occurred using 10 µg/mL (10.74 ± 2.86 and 9.60 ± 6.89%) and 50 µg/mL of extract (48.37 ± 3.24 and 53.06 ± 6.15%), suggesting that the anti‐inflammatory mechanisms evoked by M. sylvestris may be related to modulation of these mediators. Copyright © 2014 John Wiley & Sons, Ltd.     

[1,3‐Bis(2,6‐diisopropylphenyl)imidazol‐2‐ylidene]chloridogold(I)

The molecule of the title compound, [AuCl(C₂₇H₃₆N₂)], which belongs to a class of potentially catalytically active N‐heterocyclic carbene complexes, has crystallographic C₂ symmetry and approximate C_2v symmetry. The structure is isostructural with the Cu^I and Ag^I analogues. A previous report of the structure of the title compound as its toluene solvate [Fructos et al. (2005). Angew. Chem. Int. Ed. 44 , 5284–5288] has inaccurate geometry for the complex molecule as a consequence of probable incorrect refinement in the space group Cc, instead of C2/c [Marsh (2009). Acta Cryst. B 65 , 782–783]. The Au—C bond length of 1.998 (4) Å in the title compound is more consistent with the mean distance of 1.979 (14) Å found in 52 other reported [AuCl(carbene)] complexes than with the shorter distance of 1.942 (3) Å given for the refinement in the space group Cc for the toluene solvate and the value of 1.939 Å obtained from the recalculation of that structure in C2/c.